Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • Euretina 2026 Vienna
      • On-Demand
      • Welcome
      • Congress Daily
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Programme
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Ramin Tadayoni Award
    • Mentorship Programme
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • Euretina 2026 Vienna
      • On-Demand
      • Welcome
      • Congress Daily
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Programme
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Ramin Tadayoni Award
    • Mentorship Programme
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Multimodal imaging of retinocytomas: A retrospective case series

Author: Adwaita Nag (India)

Co-authors: Vikas Khetan

Purpose

Retinocytoma is a retinal tumor regarded as the benign equivalent of retinoblastoma (RB) but with the same genetic implications. Gallie et al reported a characteristic clinical triad, which, along with an absence of progression, could diagnose a retinoma: translucent retinal mass (“fish flesh”), calcific nodules (“cottage cheese”) and retinal pigment epithelial (RPE) alterations. Presence of retinocytoma is definitive evidence of the presence of the RB1 gene. This is especially important in patients with unilateral RB, normal contralateral eye and no family history of retinoblastoma. Knowledge of retinocytoma is limited due to its rarity and based mainly on clinical findings. Few histopathologic studies, performed on eyes that have been enucleated on suspicions of malignancy, reported well-differentiated features. However, there are infrequent reports of malignant transformation, highlighting the importance of regular follow-up with photographic documentation of lack of tumor growth. Advent of imaging modalities like OCT has made ‘optical biopsy’ possible, with a resolution similar to histological sections. Furthermore, OCT Angiography (OCTA) enables non-invasive visualization of the chorioretinal microvasculature within the tumour. This study aims to assess the role of multimodal imaging (MMI) in the diagnosis and monitoring of retinocytomas while attempting to gain a better understanding of these rare tumors.

Setting/Venue

This study includes patients diagnosed with retinocytoma at the Ocular Oncology Clinic of a tertiary ophthalmic institute in South India over a period of five years (2015-2020).

Methods

This was a retrospective case series including 12 retinocytomas in 11 eyes of 10 patients. The age of presentation, chief complaint, past and family history, previous misdiagnoses, laterality, best-corrected visual acuity (BCVA) were recorded. MMI including colour fundus photography (CFP), fundus autofluorescence (FAF), ultrasound B scan (USG), MRI brain and orbit, ultra-widefield (UWF) imaging, fundus fluorescein angiography (FFA), swept-source OCT (SS-OCT) and OCT Angiography (SS-OCTA) were performed. Children below 10 years of age were examined under general anesthesia and underwent Retcam imaging. The presence of the three classical features and additional features like chorioretinal atrophy (CRA), irregular blood vessels, vitreous deposits or cystic changes were documented. Size of each tumour was measured along its largest dimension in disc diameters (DD). Their location was categorized as: • Zone 1 – circle centered on foveola, including optic disc • Zone 2 – ring surrounding zone 1, extending up to posterior end of vortex veins (mid-periphery) • Zone 3 –area beyond zone 2 (far periphery) Qualitative analysis of retinal layers and choroid on SS-OCT and the superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris (CC) on SS-OCTA was also performed. At each visit, the tumor was documented as stable, progressing or regressing.

Results

The median age was 11.5 years and 80% were males. A family history of retinoblastoma was present in 20%. The mean size of the retinocytomas was 6.45DD. 33.33% of tumours involved zone 1, 25% involved zone 2 and zone 3 each and 16.67% involved both zones 1 and 2. Macular involvement was present in 27.27%, optic disc in 18.18% while both were affected in 18.18%. Translucent mass was present in 66.67%, calcification in 50%, RPE disturbance in 75% and the entire triad in 50% of tumours. 66.67% had CRA. FAF revealed heterogenous pattern with iso- and hyper-autofluorescence centrally and hypo-autofluorescence peripherally. A superficial hyperreflective layer was found in 100% of eyes that underwent OCT, corresponding to the retinal nerve fibre layer (RNFL). In 50% of eyes, inner retinal layers (IRL) including ganglion cell layer (GCL), inner plexiform (IPL) and inner nuclear layer (INL) were further discernible. 66.67% had cystic spaces within the tumour, mainly in the INL. Choroidal thinning was universal. OCT angiography showed choriocapillaris loss with intact SCP and DCP. FFA showed diffuse faint hyperfluorescence with fuzzy margins and corkscrewing of overlying vessels. During a mean follow-up of 5 years, none of the tumours exhibited growth or malignant transformation.

Conlusions

This is the largest case series to date describing the MMI features of retinocytomas. On including CRA as a fourth finding, diagnostic yield increases from 50% to 66.67% for a combination of any 3 of the 4 features. Cysts have been previously suggested to be associated with increased malignant potential; in this study, cysts were seen in 66.67% of tumours but none exhibited malignant changes. Earlier studies have reported retinocytomas as featureless masses on OCT without any discernible layer. One case report identified a hyperreflective superficial layer. In this study, among tumours that underwent OCT, RNFL was identified in 100% and additional IRL in 50%. Preliminary neurosensory retinal differentiation in retinocytomas is a novel finding that has not been previously reported. It provides further evidence that retinocytomas arise de novo and are not spontaneously regressed RBs as previously believed. Retinoblastomas have full-thickness retinal replacement with disorganized tissue on OCT. Preserved retinal layers on OCT not only indicate a benign nature but can also be used to distinguish retinocytomas from RB. FFA and OCTA findings suggest intrinsic vascularity of retinocytomas. Thus MMI provides new insights into the pathology and natural history of retinocytomas and is an excellent tool for serial monitoring.

Financial Disclosure

NIL

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

European Society of Retina Specialists c/o Congrex Switzerland
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

General Enquires: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • Euretina 2026 Vienna
      • On-Demand
      • Welcome
      • Congress Daily
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Programme
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Ramin Tadayoni Award
    • Mentorship Programme
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login